Comparative Efficacy and Safety of Daily Versus Alternate Day Dosing of Rosuvastatin in Dyslipidemic Patients: A Prospective, Randomized, Open Label Study. IJPRMH. 2025;1(1):10-19. doi:10.66328/ijprmh.2025.010103